INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 62 filers reported holding INHIBRX INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $348,834 | -77.3% | 19,010 | -67.9% | 0.00% | – |
| Q2 2023 | $1,535,119 | +450.6% | 59,134 | +300.3% | 0.00% | – |
| Q1 2023 | $278,785 | -20.1% | 14,774 | +4.4% | 0.00% | – |
| Q4 2022 | $348,706 | +34.6% | 14,152 | -1.8% | 0.00% | – |
| Q3 2022 | $259,000 | +99.2% | 14,407 | +25.5% | 0.00% | – |
| Q2 2022 | $130,000 | -48.6% | 11,477 | +1.0% | 0.00% | – |
| Q1 2022 | $253,000 | -88.9% | 11,358 | -78.2% | 0.00% | -100.0% |
| Q4 2021 | $2,280,000 | +14.3% | 52,196 | -12.8% | 0.00% | 0.0% |
| Q3 2021 | $1,994,000 | +752.1% | 59,858 | +604.1% | 0.00% | – |
| Q2 2021 | $234,000 | – | 8,501 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
| Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
| RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
| Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
| Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
| Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
| VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
| Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
| Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
| ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |